Related Experiment Video
Updated: Nov 18, 2025
03:53
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
1.6K
The swift knowledge development path of COVID-19 research: the first 150 days
Mei Hsiu-Ching Ho1, John S Liu1
1National Taiwan University of Science and Technology, No.43, Keelung Rd., Sec.4, Da'an Dist., Taipei, 10607 Taiwan, ROC.
Scientometrics
|February 8, 2021
Summary
The rapid accumulation of COVID-19 research, including scientific literature, was accelerated by diverse journal platforms and a sense of national urgency. This early-stage knowledge growth was also inspired by journal editorials.
Area of Science:
- Virology
- Epidemiology
- Medical Literature Analysis
Background:
- The COVID-19 pandemic spurred unprecedented global research output.
- A vast body of scientific literature emerged rapidly following the virus outbreak.
Purpose of the Study:
- To analyze the factors contributing to the rapid accumulation of COVID-19 literature in the initial 150 days.
- To understand the drivers of early-stage knowledge generation during a pandemic.
Main Methods:
- Literature analysis of COVID-19 publications within the first 150 days.
- Qualitative assessment of contributing factors such as journal diversity, national urgency, and editorial influence.
Main Results:
- Early COVID-19 knowledge accumulation was facilitated by a wide range of journal platforms.
- A strong sense of national urgency and pressure significantly expedited research publication.
- Inspiration drawn from journal editorials played a role in accelerating scientific output.
Conclusions:
- The rapid dissemination of scientific information during the COVID-19 pandemic was a multi-faceted process.
- Effective knowledge translation relies on diverse publication venues, timely research, and community engagement.
Related Concept Videos
01:11Clinical Trials: Overview
4.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K
01:28Preclinical Development: Overview
5.5K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.5K
01:05Single Nucleotide Polymorphisms-SNPs
17.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.3K
01:18Steps in Outbreak Investigation
342
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
342